Prevention and management of hereditary breast cancer

被引：106

作者：

Narod, SA

Offit, K

机构：

[1] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada

[2] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期

关键词：

D O I：

10.1200/JCO.2005.10.035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1656 / 1663

页数：8

共 97 条

[61] Use of proteomic patterns in serum to identify ovarian cancer [J].

Petricoin, EF ;

Ardekani, AM ;

Hitt, BA ;

Levine, PJ ;

Fusaro, VA ;

Steinberg, SM ;

Mills, GB ;

Simone, C ;

Fishman, DA ;

Kohn, EC ;

Liotta, LA .

LANCET, 2002, 359 (9306) :572-577

[62] BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients [J].

PetrijBosch, A ;

Peelen, T ;

vanVliet, M ;

vanEijk, R ;

Olmer, R ;

Drusedau, M ;

Hogervorst, FBL ;

Hageman, S ;

Arts, PJW ;

Ligtenberg, MJL ;

MeijersHeijboer, H ;

Klijn, JGM ;

Vasen, HFA ;

Cornelisse, CJ ;

vantVeer, LJ ;

Bakker, E ;

vanOmmen, GJB ;

Devilee, P .

NATURE GENETICS, 1997, 17 (03) :341-345

[63] A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families [J].

Phelan, CM ;

Kwan, E ;

Jack, E ;

Li, S ;

Morgan, C ;

Aubé, J ;

Hanna, D ;

Narod, SA .

HUMAN MUTATION, 2002, 20 (05) :352-357

[64] Evidence-based management options for women at increased breast/ovarian cancer risk [J].

Pichert, G ;

Bolliger, B ;

Buser, K ;

Pagani, O .

ANNALS OF ONCOLOGY, 2003, 14 (01) :9-19

[65]

Pierce L, 2003, BREAST CANCER RES TR, V82, pS7

[66] Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations [J].

Pierce, LJ ;

Strawderman, M ;

Narod, SA ;

Oliviotto, I ;

Eisen, A ;

Dawson, L ;

Gaffney, D ;

Solin, LJ ;

Nixon, A ;

Garber, J ;

Berg, C ;

Isaacs, C ;

Heimann, R ;

Olopade, OI ;

Haffty, B ;

Weber, BL .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3360-3369

[67]

Quinn JE, 2003, CANCER RES, V63, P6221

[68]

REBBECK T, 1999, JNCI-J NATL CANCER I, V91, P1457

[69] Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations [J].

Rebbeck, TR ;

Lynch, HT ;

Neuhausen, SL ;

Narod, SA ;

van't Veer, L ;

Garber, JE ;

Evans, G ;

Isaacs, C ;

Daly, MB ;

Matloff, E ;

Olopade, OI ;

Weber, BL .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1616-1622

[70] Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group [J].

Rebbeck, TR ;

Friebel, T ;

Lynch, HT ;

Neuhausen, SL ;

van't Veer, L ;

Garber, JE ;

Evans, GR ;

Narod, SA ;

Isaacs, C ;

Matloff, E ;

Daly, MB ;

Olopade, OI ;

Weber, BL .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1055-1062

← 1 2 3 4 5 6 7 8 9 10 →